Skip to main content
Scholars@Duke
Menu
About
Schools / Institutes
Browse
Relapsed or Refractory Multiple Myeloma: ABBV-383 vs Standard Available Therapies in Subjects with RRMM (3L+ RRMM Monotherapy Study)
Clinical Trial Grant
Duke Scholars
Principal Investigator
Cristina Gasparetto
Medicine, Hematologic Malignancies and Cellular Therapy
Awarded By
AbbVie Inc.
Start Date
March 19, 2025
End Date
March 18, 2028
Awarded By
AbbVie Inc.
Start Date
March 19, 2025
End Date
March 18, 2028
